[New directions in pharmacotherapy for bronchial asthma].
Klin
M J
MJ
Katedry i Zakładu Farmakologii Klinicznej Sl. AM, Katowicach.
Brewczyński
P Z
PZ
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000318:Adrenergic beta-Agonists / Q000627:therapeutic use; D001249:Asthma / Q000188:drug therapy*; D016572:Cyclosporine / Q000627:therapeutic use; D015777:Eicosanoids / Q000037:antagonists & inhibitors; D006801:Humans; D010972:Platelet Activating Factor / Q000037:antagonists & inhibitors; D015221:Potassium Channels / Q000187:drug effects
D000305:Adrenal Cortex Hormones; D000318:Adrenergic beta-Agonists; D015777:Eicosanoids; D010972:Platelet Activating Factor; D015221:Potassium Channels; D016572:Cyclosporine
Nowe kierunki w farmakoterapii dychawicy oskrzelowej.